This application is a 371 of PCT/ES02/00231, filed on May 16, 2002, which claims benefit of priority to ES 200101200, filed on May 16, 2001.
The invention refers to the use of oral compositions for the treatment of non-diabetic mammals, including humans suffering from obesity and/or overweight. The